The ideal carrier solution for HIPEC with oxaliplatin should provide a uniform distribution of the cytotoxic drug and heat, with minimal loss of volume during perfusion. This requires minimal transport of fluid and electrolytes from theperitoneal compartment to the plasma, and stability of the drug in the carrier solution. As oxaliplatin can react with chloride ions, causing degrad